Evaluation of Objective Measures of Smoking Status--A Prospective Clinical Study in a Group of Head and Neck Cancer Patients Treated With Radiotherapy

Acta Oncol. 2003;42(2):154-9. doi: 10.1080/02841860310005020.

Abstract

The present study was undertaken to evaluate objective measures of the smoking status of head and neck cancer patients during the course of radiotherapy. This was done by conducting a weekly structured interview, and measurement of carbon monoxide in expired air and of serum concentration of cotinine, the major metabolite of nicotine. These methods were tested prospectively in a series of 20 patients with head and neck cancer treated with radiotherapy. The results showed significant differences in the levels of end-expired carbon monoxide as well as serum cotinine among the different self-reported smoking groups. Combining the two objective measures and the interview data, the study revealed that up to 50% of self-reported non-smokers were in fact smoking actively. Measurement of end-expired carbon monoxide levels was found to be a precise indicator of smoking in the hours preceding measurement. Serum cotinine was a valuable measure of true smoking status. Assuming that this assay reflects the true smoking status, sensitivity, specificity and positive predictive value of self-reporting in this patient population was 79%, 80%, and 92%, respectively. In research aiming to investigate possible relations between smoking and radiotherapy, it is recommended that patients' smoking status be evaluated objectively as a supplement to self-reporting, at least in the head and neck cancer patients.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Breath Tests
  • Carbon Monoxide / metabolism*
  • Cotinine / blood*
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Interviews as Topic
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Self Disclosure*
  • Sensitivity and Specificity
  • Smoking Cessation / methods*
  • Smoking*

Substances

  • Biomarkers
  • Carbon Monoxide
  • Cotinine